GENE ONLINE|News &
Opinion
Blog

2022-08-04|

Doctor Tailoring Cognitive Therapies for Patient Personalization Wins Grand Prize

by Max Heirich
Share To

Dr. Robert Reinhart, an Assistant Professor of Psychological & Brain Sciences and Biomedical Engineering at Boston University (BU), won the grand prize of the Science & PINS Prize for Neuromodulation. Reinhart won for his work in using new technologies to create personalized cognitive therapies for patients.

Related Article: MGI Wins Company Innovation of the Year at 2022 Globee® Awards for Advanced COVID-19 Response Efforts

Cognitive Decline and its Therapies

Cognitive disorders such as aging and obsessive-compulsive disorder (OCD) number some of the most disabling mental conditions for a person to have. Slow symptom resolution, as well as side effects, limit cognitive therapies that currently treat these conditions. This results from these therapies not being designed personally for each patient.

Dr. Reinhart and his team research improvements for the personalization of cognitive therapies. Using transcranial alternating current stimulation (tACS) technology, Reinhart noninvasively manipulates the rhythmic activity of a patient’s brain. This allows him and his team to gain immediate control over components of human cognition, resulting in a treatment explicitly tailored to each patient’s anatomy. They achieved this method after utilizing and improving upon a new neuromodulation approach known as high-definition transcranial alternating current stimulation (HD-tACS).

This technology uses electrodes attached to a patient’s head, delivering currents to water-soluble electrode gel upon the skin. While this occurs in twenty-minute sessions, the patient comfortably sits upright and performs cognitive tasks. 

Using HD-tACS, Reinhart delivered personalized cognitive therapies to improve memory in elderly patients and treated factors of ODC in others. However, despite Reinhart finding positive results in his tests, his team is currently the only one to achieve this. 

Winning the Science & PINS Prize for Neuromodulation.

The Science & PINS Prize, an annual contest, awards scientists for outstanding research. Whoever wins this award receives $25,000 in addition to the publishing of their essay in Science.

Dr. Reinhart won the 2022 grand prize for his work developing cognitive therapies. On his work, Dr. Caitlin Czajka and Dr. Mattia Maroso, Senior Editors at Science Translational Medicine, said, “The work by Dr. Reinhart, beautifully presented in his winning essay, highlights the potential of neuromodulation for treating cognitive impairments. Dr. Reinhart and colleagues utilized non-invasive transcranial alternating current stimulation to improve age-related memory function and reduce symptoms of obsessive-compulsive behaviors. The results presented by Dr. Reinhart support using this customizable, non-pharmacological intervention to maintain cognitive abilities throughout life.”

Reinhart plans on continuing his work in developing new cognitive therapies to treat a wide range of conditions. Though he asserts that he will continue to develop treatments for aging and OCD, he intends to treat Alzheimer’s, bipolar, and schizophrenia. 

Related Article: Billions of Research Dollars May Have Been Wasted Due to Fraudulent Alzheimer’s Study

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Scientists Make Rat-Human Hybrid Brain for Neuropsychiatric Research Purposes
2022-10-24
Sosei Heptares and Abbvie Partner in Potential $1.2 Billion Neurological Disease Deal
2022-08-02
Human Longevity Plans to Merge With Blank Check Company to Go Public
2022-06-22
LATEST
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Moving Beyond COVID With mRNA Technology
2023-01-18
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
2023-01-17
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Scientists Study Imaging Probes in First-Ever Amputated Human Limb Model
2023-01-16
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!